AANEM News Express

Gender as a Modifying Factor Influencing Myotonic Dystrophy Type 1 Phenotype Severity and Mortality

    5/4/2016
This study in PLOS ONE is a nationwide, multiple databases cross-sectional observational study of adult Myotonic Dystrophy Type 1 patients showed that there are gender differences in the phenotype.

Long-term Safety and Efficacy of Mexiletine for Patients With Skeletal Muscle Channelopathies

    4/20/2016
Neuromuscular physicians often approach mexiletine initiation with trepidation, because the medication may lead to cardiac arrhythmias. This study in JAMA Neurology examined the data.

oVEMP as a Test for Myasthenia Gravis

    4/6/2016
This study in Neurology shows that Ocular Vestibular Evoked Myogenic Potentials (oVEMP) may be a useful test for evaluation of patients with myasthenia gravis. It offers two potential advantages compared to currently available techniques.

Open Payment Review and Dispute Period

    4/6/2016
On Friday, April 1, 2016 the Centers for Medicare & Medicaid Services (CMS) announced the beginning of the review and dispute period for the Open Payments data publication. This review period lasts for 45 days.

TUDCA in the Treatment of ALS

    3/23/2016
This pilot study in the European Journal of Neurology showed promise for the use of TUDCA in the slowing the progression of ALS.

Serum AChR Antibody Testing is More Sensitive in OMG than Previously Reported

    3/9/2016

Advocacy in Washington, D.C. & Call to Action

    3/9/2016
AANEM representatives recently returned from a productive trip to Washington, D.C. where they met with several patient groups and Senate offices to advocate for a national mandate setting quality standards based on AANEM’s EDX Laboratory Accreditation program.

Comparative Billing Reports in EDX Medicine: An Analysis

    3/9/2016
Approximately 4,300 Medicare providers of electrodiagnostic (EDX) tests received comparative billing reports (CBRs) this past February. The reports are intended to give providers an opportunity to compare themselves to their peers (based on the specialty they billed Medicare most often under), check their records against data in CMS files, and review Medicare (and AANEM) guidelines to ensure compliance

Oral Steroids for Acute Radiculopathy Due to a Herniated Lumbar Disk

    2/24/2016

CMS Extends Attestation Deadline

    2/24/2016
The Centers for Medicare and Medicaid Services (CMS) announced that they have extended the attestation deadline for the Medicare and Medicaid Electronic Health Record (EHR) Incentive Programs to Friday, March 11, 2016